Antihypertensive medications and risks of recurrence and mortality in luminal, triple-negative, and HER2-overexpressing breast cancer. - Lorona NC; Cook LS; Tang MC; Hill DA; Wiggins CL; Li CI (Cancer causes & control : CCC, 2021)